Difference between revisions of "Pharmacy"
From Dog
Line 4,131: | Line 4,131: | ||
| width="20%" height="10" align="left" valign="top" | <font size="2" face="Arial">q 24hrs, divided doses</font> | | width="20%" height="10" align="left" valign="top" | <font size="2" face="Arial">q 24hrs, divided doses</font> | ||
|- | |- | ||
− | | width="20%" height="10" align="left" valign="top" | <font size="2" face="Arial"> | + | | width="20%" height="10" align="left" valign="top" | <font size="2" face="Arial">Warfarin</font> |
− | | width="22%" height="10" align="left" valign="top" | <font size="2" face="Arial">[[ | + | | width="22%" height="10" align="left" valign="top" | <font size="2" face="Arial">[[thromboembolism]]</font> |
− | | width="18%" height="10" align="left" valign="top" | <font size="2" face="Arial"> | + | | width="18%" height="10" align="left" valign="top" | <font size="2" face="Arial">0.06 - 0.20 mg/kg</font> |
| width="20%" height="10" align="left" valign="top" | <font size="2" face="Arial">PO</font> | | width="20%" height="10" align="left" valign="top" | <font size="2" face="Arial">PO</font> | ||
− | | width="20%" height="10" align="left" valign="top" | <font size="2" face="Arial">q | + | | width="20%" height="10" align="left" valign="top" | <font size="2" face="Arial">q 24 hrs. Maintain PTT at 2 - 2.5 times normal</font> |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
| width="20%" height="10" align="left" valign="top" | <font size="2" face="Arial">[[Xylazine]]</font> | | width="20%" height="10" align="left" valign="top" | <font size="2" face="Arial">[[Xylazine]]</font> | ||
| width="22%" height="10" align="left" valign="top" | <font size="2" face="Arial">Muscle relaxation</font> | | width="22%" height="10" align="left" valign="top" | <font size="2" face="Arial">Muscle relaxation</font> | ||
− | | width="18%" height="10" align="left" valign="top" | <font size="2" face="Arial">1.1-2.2mg/kg</font> | + | | width="18%" height="10" align="left" valign="top" | <font size="2" face="Arial">1.1 - 2.2mg/kg</font> |
| width="20%" height="10" align="left" valign="top" | <font size="2" face="Arial">IM, SQ</font> | | width="20%" height="10" align="left" valign="top" | <font size="2" face="Arial">IM, SQ</font> | ||
| width="20%" height="10" align="left" valign="top" | <font size="2" face="Arial">stat</font> | | width="20%" height="10" align="left" valign="top" | <font size="2" face="Arial">stat</font> | ||
Line 4,155: | Line 4,149: | ||
| width="20%" height="10" align="left" valign="top" | | | width="20%" height="10" align="left" valign="top" | | ||
|- | |- | ||
− | | width="20%" height="10" align="left" valign="top" | <font size="2" face="Arial"> | + | | width="20%" height="10" align="left" valign="top" | <font size="2" face="Arial">Zafirlukast</font> |
| width="22%" height="10" align="left" valign="top" | <font size="2" face="Arial">Leukotriene receptor antagonist</font> | | width="22%" height="10" align="left" valign="top" | <font size="2" face="Arial">Leukotriene receptor antagonist</font> | ||
− | | width="18%" height="10" align="left" valign="top" | <font size="2" face="Arial">0.15-0.2mg/kg</font> | + | | width="18%" height="10" align="left" valign="top" | <font size="2" face="Arial">0.15 - 0.2mg/kg</font> |
| width="20%" height="10" align="left" valign="top" | <font size="2" face="Arial">PO</font> | | width="20%" height="10" align="left" valign="top" | <font size="2" face="Arial">PO</font> | ||
− | | width="20%" height="10" align="left" valign="top" | <font size="2" face="Arial">q 12 - | + | | width="20%" height="10" align="left" valign="top" | <font size="2" face="Arial">q 12 - 24 hrs</font> |
|- | |- | ||
| width="20%" height="10" align="left" valign="top" | <font size="2" face="Arial">[[Zidovudine]] (AZT)</font> | | width="20%" height="10" align="left" valign="top" | <font size="2" face="Arial">[[Zidovudine]] (AZT)</font> | ||
| width="22%" height="10" align="left" valign="top" | <font size="2" face="Arial">Antiviral</font> | | width="22%" height="10" align="left" valign="top" | <font size="2" face="Arial">Antiviral</font> | ||
− | | width="18%" height="10" align="left" valign="top" | <font size="2" face="Arial">5-20 mg/kg</font> | + | | width="18%" height="10" align="left" valign="top" | <font size="2" face="Arial">5 - 20 mg/kg</font> |
| width="20%" height="10" align="left" valign="top" | <font size="2" face="Arial">SQ, PO</font> | | width="20%" height="10" align="left" valign="top" | <font size="2" face="Arial">SQ, PO</font> | ||
| width="20%" height="10" align="left" valign="top" | <font size="2" face="Arial">q 8 - 12 hrs</font> | | width="20%" height="10" align="left" valign="top" | <font size="2" face="Arial">q 8 - 12 hrs</font> | ||
Line 4,169: | Line 4,163: | ||
| width="20%" height="10" align="left" valign="top" | <font size="2" face="Arial">Zinc</font> | | width="20%" height="10" align="left" valign="top" | <font size="2" face="Arial">Zinc</font> | ||
| width="22%" height="10" align="left" valign="top" | <font size="2" face="Arial">Antioxidant</font> | | width="22%" height="10" align="left" valign="top" | <font size="2" face="Arial">Antioxidant</font> | ||
− | | width="18%" height="10" align="left" valign="top" | <font size="2" face="Arial">2-3 mg/kg</font> | + | | width="18%" height="10" align="left" valign="top" | <font size="2" face="Arial">2 - 3 mg/kg</font> |
| width="20%" height="10" align="left" valign="top" | <font size="2" face="Arial">PO</font> | | width="20%" height="10" align="left" valign="top" | <font size="2" face="Arial">PO</font> | ||
| width="20%" height="10" align="left" valign="top" | <font size="2" face="Arial">q 24 hrs</font> | | width="20%" height="10" align="left" valign="top" | <font size="2" face="Arial">q 24 hrs</font> | ||
|- | |- | ||
− | | width="20%" height="18" align="left" valign="top" | <font size="2" face="Arial"> | + | | width="20%" height="18" align="left" valign="top" | <font size="2" face="Arial">Zonisamide</font> |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
| width="22%" height="18" align="left" valign="top" | <font size="2" face="Arial">[[Epilepsy]]</font> | | width="22%" height="18" align="left" valign="top" | <font size="2" face="Arial">[[Epilepsy]]</font> | ||
| width="18%" height="18" align="left" valign="top" | <font size="2" face="Arial">5 mg/kg</font> | | width="18%" height="18" align="left" valign="top" | <font size="2" face="Arial">5 mg/kg</font> |
Revision as of 05:54, 29 April 2013
Below are listed some of the common drugs used in canine medicine. See the FDA Green book for a comprehensive list of approved veterinary medicines.
Drug |
Indications | Dose | Route | Frequency |
Acarbose | Diabetes mellitus | 12.5 - 20 mg | Oral | with each meal |
Acemannan | Immunomodulation | 1 - 2 mg/kg | Intralesional, IP or SQ | weekly |
Acepromazine | Sedation, restraint | 0.05 - 2.25 mg/kg | SQ, IM, PO | q 8 - 12hrs |
Aortic thromboembolism | 0.15 - 0.3 mg/kg | SQ | q 8 - 12hrs | |
Amphetamine and pseudoephedrine toxicosis | 0.05 -1.0 mg/kg | IV, IM, SQ | q 8 - 12hrs | |
Acetazolamide | Glaucoma | 5 - 10 mg/kg | PO | q 8 - 12hrs |
Acetylcysteine | Mucolytic (Asthma), Acetaminophen toxicity | 140 mg/kg | IV | loading dose |
5 - 10 mg/kg | PO | every 12 hours | ||
Acetylsalicylic acid | Antipyretic | 6 - 10 mg/kg | PO | q 48 - 72hrs |
Antithrombotic | 25 mg/kg | PO | 2 times/wk | |
Anti-inflammatory | 10 - 20 mg/kg | PO | q 48 hrs | |
Analgesia | 10 mg/kg | PO | q 48hrs | |
Actinomycin D | Chemotherapy / antimicrobial | 0.5 - 0.9 mg/m2 | IV | once every 3 weeks |
S-Adenosylmethionine | Glutathione replenisher - chronic hepatitis, hepatic encephalopathy, portosystemic shunt | 20 - 30 mg/kg | PO | q 24hrs |
Aglepristone | Mesalliance | 10mg/kg | SQ | stat |
Albendazole | Lungworm | 50 mg/kg | PO | daily for 21 days |
Albuterol sulphate | Bronchodilation | 90 µg metered dose | inhaler | q 6 - 8hrs |
Alfaxan | general anesthesia | 1 - 2 mL per 5 kg bodyweight | IV | bolus or slowly IV |
Allopurinol | Urate uroliths | 10 mg/kg | PO | q 8 - 12hrs for 30 days |
Alprazolam | Anxiolytic | 0.125 - 0.25 mg/dog | PO | q 12hrs |
Aluminium carbonate gel | Phosphate binder | 10 - 30 mg/kg | PO with meals | q 8hrs |
Aluminium hydroxide | Antacid | 20 - 30 ml | PO | q 2 - 4 hrs |
Phosphate binder | 30 - 90 mg/kg | PO with meals | q 8 - 24 hrs | |
Amantadine | Analgesia for chronic pain | 3 - 5 mg/kg | PO | daily for 7 - 14 days |
Amikacin | Susceptible infections | 15 - 22 mg/kg | IM, IV, SQ | q 24hrs |
Aminophylline | Asthma | 4 - 6.6 mg/kg | PO | q 8 - 12hrs |
2 - 5 mg/kg | IV infusion | q 12hrs | ||
5-aminosalicylic acid | ulcerative colitis | 20 mg/kg | PO | q 24 hrs |
Amitriptyline (Endep-10) | Analgesia | 2 mg/kg | PO | q 24 hrs |
Amlodipine besylate | Systemic hypertension | 0.625 mg | PO | q 24 hrs |
Ammonium chloride | Struvite dissolution | 800 mg | PO | q 24 hrs |
Amoxicillin/clavulanate | Susceptible infections | 10 - 20 mg/kg | PO | q 12 hrs |
Amoxil | Susceptible infections | 4 - 11 mg/kg | PO | q 12 hrs |
Amphetamine | CNS stimulation during certain toxicoses | 5 mg | PO | q 12 hrs |
Amphotericin B | Systemic mycoses | 0.15 - 1 mg/kg in 5% dextrose | IV | q 48 hrs to a total cumulative dose of 10mg/kg |
SQ | diluted 1:10 in saline | |||
Ampicillin | Susceptible infections | 20 - 60 mg/kg | PO | q 8 - 12 hrs |
Amprolium | Coccidiosis | 60 - 100 mg/kg | PO | q 24 hrs x 5 d |
With sulfadimethoxine | 150 mg/kg | PO | q 24 hrs x 5d | |
Ascorbic acid | Antioxidant | 25 - 125 mg/kg/day | PO | q 24hrs |
Acetaminophen toxicosis | 30 mg/kg | PO, SQ | 6 - 7 treatments | |
Asparaginase | Lymphosarcoma | 10,000 U/m2 | IV | weekly as part of a protocol |
Aspirin | Antipyretic | 6 - 10 mg/kg | PO | q 48 - 72hrs |
Atenolol | ß1-blocker for Hypertrophic cardiomyopathy + Hypertension | 6.25 mg/cat | PO | q 24hrs |
Atipamezole | Medetomidine reversal | equivolume | IM | as needed |
Atovaquone | Toxoplasma spp, Babesia spp, Pneumocystis spp | 10 - 15 mg/kg with fatty meal | PO | q 8 hrs x 21 days |
Atracurium | Paralytic anaesthetic agent | 0.1 - 0.25 mg/kg | IV | repeated q 30mins |
Atropine | Pre-anaesthetic medicant, Sinus bradycardia | 0.02 - 0.04 mg/kg | IM, IV, SQ | as required |
Organophosphate toxicity | 0.2 - 2.0 mg/kg | IM, SQ | q 2hrs | |
Aurothioglucose | Pemphigus, periodontitis and pododermatitis | 1 - 2 mg | IM | weekly |
Azathioprine | Enteritis | 0.2 -0.3 mg/kg | PO | q 24 - 48hrs |
Immune-mediated haemolytic anaemia | 1 mg/kg | PO | q 24 - 48hrs | |
Immunosuppression | 1.1 mg/kg | PO | q 48hrs | |
Azithromycin | Susceptible infections | 5 mg/kg | PO | q 24 - 48 hrs |
Susceptible infections | 80 mg stat | PO | weekly x 3 | |
Azodyl | Probiotic | 1 capsule | PO | q 12 - 24 hrs |
Aztreonam | Susceptible infections | 12 - 25 mg/kg | IV, IM | q 8 - 12 hrs |
Baytril | Susceptible infections | 5.0 - 20.0 mg/kg | PO, SQ, IM, IV (with caution - may cause blindness) | q 24hrsfor 7 - 10 days |
Beclomethasone | Anti-inflammatory | 200 mg | Inhalant | as required |
Benazepril | Afterload reduction (chronic renal disease, congestive heart failure) | 0.25 - 0.5 mg/kg | PO | q 24hrs |
Benzimidazole | Trypanosomiasis | 5 mg/kg | PO | q 24hrs for 4 months |
Benzocaine | Local anaesthetic | 1 - 5 ml | SQ | as required |
Benzoyl peroxide | Seborrhoea, antibacterial | leave on skin for 10mins | q 3 - 4 days for 2 weeks | |
Betamethasone | Anti-inflammatory | 0.1 - 0.2 mg/kg | PO | q 12 - 24hrs |
Bethanechol | Bladder atony, dysautonomia, cystitis | 1.25 - 5.0 mg | PO | q 8- 12 hrs |
Bisacodyl | Constipation | 2 - 5 mg/dog | PO | q 24hrs as needed |
Bleomycin | Chemotherapy | 10 µg/m2 | IV, SQ | q 24hrs for 4 days, then weekly; max dose 200mg/m2 |
Bran | Stool softener | 1 - 2 teaspoons/400g food | PO | as needed |
Brewer's yeast | B vitamin source | 0.2 mg | PO | q 24 hrs |
Bromhexine hydrochloride | Mucolytic for asthma | 2 mg/kg | PO | q 12 hrs for 7 - 10 days |
Bromide | Anticonvulsant | 30 - 60 mg/kg | PO | q 12 hrs |
Bromocriptine | Cushing's syndrome, False pregnancy, lactation cessation | 10 - 30 µg/kg | PO | q 24 hrs for 10 - 16 days |
Budesonide | Asthma, ulcerative colitis | 1 mg/dog | PO | daily |
Bunamidine | Cestodes - Taenia spp, Spirometra spp, Diphyllobothrium spp | 20 - 50 mg/kg | PO | after 3 hr fast |
Bupivicaine hydrochloride | Local Anaesthetic | 0.22 - 3.0 ml/cat | Epidural | stat |
Buprenorphine | Opioid analgesia | 0.005 - 0.01 mg/kg | IV, IM | q 4 - 8 hrs |
Buspirone | Behavioural therapy | 0.5 - 1.0 mg/kg | PO | q12-24hrs |
Busulfan | Chronic myelocytic leukaemia | 3 - 4mg/m2 or 0.1 mg/kg | PO | q 24 hrs |
Butorphanol | Preanesthetic | 0.05 - 0.4mg/kg with ACP | IV, IM, SQ | |
Antiemetic | 0.2 - 0.6 mg/kg | SQ, IM, IV | ||
Analgesia | 0.1 - 0.8 mg/kg | PO | q 6 - 12 hrs | |
Cabergoline | Induction of estrus/abortion/pyometra | 5 μg/kg/day | PO, SQ | q 24 hrs |
Calcitriol | Hypoparathyroidism, hyperparathyroidism | 1.5 - 3.0 ng/kg | PO | q 24 hrs |
Calcium carbonate | Nutritional supplement | 1/2 tsp | PO | daily |
Phosphate binder | 60 - 100 mg/kg | PO | daily | |
Calcium chloride 10% | Ventricular asystole | 1 ml/9kg or 0.1 - 0.3ml/kg | IV (slowly) | stat |
Hypocalcaemia | 1 ml/9kg | IV | stat | |
Calcium citrate | Calcium replacement, cystitis | 10 - 30 mg/kg | PO | q 8 hrs |
Calcium EDTA | Lead poisoning | 100 mg/kg/day | SQ | daily for 5 days |
Calcium gluconate | Ventricular asystole | 0.5 - 1.5 ml/kg | IV (slowly) | as required |
Hypocalcemia, hyperkalemia | 0.5 - 1.5 ml/kg | IV (slowly) | as required | |
Capstar | Fleas | 1 tab | PO | daily as needed |
Captopril | Vasodilator | 2 - 3 mg/dog | PO | q 8 - 12 hrs |
3 - 6.25 mg/dog | PO | q 12 hrs | ||
Carbenicillin | cystitis | 10 - 55 mg/kg | PO | q 8hrs |
Carboplatin | Chemotherapy | 200 mg/m2 | IV | q 4 weeks |
Carmustine | Chemotherapy | 50 mg/m2 | IV | q 6 weeks |
Carprofen | Analgesia | 1 - 4 mg/kg | SQ | stat |
0.5-1.0 mg/kg | PO | q 24hrs | ||
Cartrofen | Analgesia | 1 - 4 mg/kg | SQ | stat |
Cefadroxil | Susceptible infections | 10 mg/kg | PO | q 24 hrs for 1 - 4 weeks |
Cefovecin | Susceptible infections | 8 mg/kg (0.5 cc) | SQ | q 2 weeks x 3 |
Cephalexin | Susceptible infections | 10 - 35 mg/kg | PO | q 8 - 12 hrs |
Anti-emetic | 1.0 mg/kg | SQ/PO | q 24 hrs for 4 days, then rest 2 days | |
Charcoal, activated | Adsorbent for poisonings | 1 - 8 g/kg | PO | as needed |
Chlorambucil | Chemotherapy, ulcerative colitis | 0.1 - 0.5 mg/kg | PO | q 48 - 72 hrs |
pemphigus | 0.1 - 0.2 mg/kg | PO | q 48 hrs with prednisolone | |
Chloramphenicol | Susceptible infections | 10 mg/kg | PO | q 12hrs |
Chlorhexidine 0.5% | Burns | dilute 1:40 with saline | topically | q 24hrs |
Chlorothiazide | Diuretic | 10 - 40 mg/kg | PO | q 12 hrs |
Partial ADH deficiency | 20 - 40 mg/kg | PO | q 12 hrs | |
Chlorpheniramine | Antihistamine | 1 - 2 mg/dog | PO | q 8 - 12 hrs |
Chlorpromazine | vomiting, pancreatitis | 0.2 - 0.5 mg/kg | IM or SQ | q 6-8hrs |
Cholecalciferol (Vit D) | hyperparathyroidism, hypocalcaemia | 500 - 2000 U/kg | PO | q 24 hrs |
Chondroitin | Arthritis | 50 - 100 mg/dog | PO | q 24 hrs |
Cimetidine | Oesophagitis, antiemetic, gastritis | 5 - 15 mg/kg | PO, IV, IM | q 8 - 12 hrs |
Ciprofloxacin | Susceptible infections | 11 - 15 mg/kg | PO | q 24 hrs |
Cisapride (Prepulsid) | constipation, megacolon | 0.5 - 5.0mg/cat | PO | q 12 hrs |
Cisplatin | Chemotherapy | 100 mg/m2 | IV | q 4 weeks x 2 |
Clarithromycin | Mycobacterium spp | 50 mg/dog | PO | q 12 hrs |
Clavulox | Susceptible infections | 10 - 20 mg/kg | PO | q 12 hrs |
Clindamycin | Anaerobic infections | 5 - 11 mg/kg | PO | q 12 hrs |
Stomatitis, Pancreatitis | 22 mg/kg | PO | q 24 hrs | |
Exocrine pancreatic insufficiency | 5 - 10 mg/kg | PO | q 6 - 8 hrs | |
Enteroepithelial cycle | 12.5 - 50 mg/kg | PO | q 12 hrs | |
Clofazimine | Mycobacterium spp | 4 - 8 mg/kg | PO | q 24 hrs for 6 weeks |
50 mg/cat | PO | q 48 hrs | ||
Clomipramine | obsessive compulsive disorders, aggression | 0.5 - 2.0 mg/kg | PO | q 12 - 24 hrs |
Clonazepam | Seizures, obsessive compulsive disorders, separation anxiety | 0.5 mg/kg | PO | q 8 - 12 hrs |
Clopidogrel | thromboembolism, hypertrophic cardiomyopathy | 18.75 - 75 mg | PO | q 24 hrs |
Clorazepate | separation anxiety | 1 - 2 mg/kg | PO | q 8 - 12 hrs |
Clotrimazole | Fungal infections | apply to lesion | topical | q 12 hrs |
Fungal infections | 60 ml of 1 g/dL of polyethylene glycol intranasal | over 1 hr under general anaesthesia | ||
Cloxacillin | Susceptible infections | 20 - 40 mg/kg | PO, IM, IV | q 4 - 8 hrs |
Coal tar shampoos | Seborrhoea | Keep in contact with skin for 10 mins | Topically | q 24 hrs |
Cobalamin | see Vit B12 | |||
Cod liver oil | 1 teaspoon / 10 kg | |||
Codeine | Pain relief | 0.5 - 4 mg/kg | PO | q 6 - 12 hrs |
Antitussive, analgesia | 0.1 - 0.3 mg/kg | PO | q 4 - 6 hrs | |
Colchicine | Antifibrotic | 0.01 - 0.3 mg/kg | PO | q 4 - 6 hrs |
Colony stimulating factor | cyclic neutropenia | 2.5 - 5.0 mg/kg (3 × 107 IU/kg) | SQ | q 24 hrs |
Convenia | Susceptible infections | 8 mg/kg (0.5 cc) | SQ | q 2 weeks x 3 |
Corticotrophin gel (ACTH) | Response test | pre-ACTH sample 0.5 - 2.2 IU/kg | IM | |
Cortisone acetate | hypoadrenocorticism | 1 mg/kg | PO, IM | q 24 hrs |
Cosyntropin | pre-ACTH sample | 0.125 mg/dog | IV | |
Cyanocobalamin | Vit B12 deficiency | 50 - 1000 µg | PO, IM, SQ | q 24 hrs |
Cyclizine | Antiemetic | 4 mg/kg | IM | q 8 hrs |
Cyclophosphamide | Chemotherapy | 100 mg/m2 | PO | q 3 weeks with doxorubicin |
Cyclosporin | thrombocytopenia, pemphigus, sebaceous adenitis | 4 - 6 mg/kg | 4hr IV infusion | q 24 hrs (avoid extravasation) |
3 - 7 mg/kg | PO | q 12 hrs | ||
Cyclosporin ophthalmic | keratoconjunctivitis sicca | 1 - 2% solution | drop in eye | q 12 hrs |
Cyclothiazide | diuretic | 0.5 - 1.0 mg/kg | PO | q 24 hrs |
Cytarabine | Chemotherapy | 30-50 mg/kg | IV, IM, SQ | once a week |
100 mg/m2 | IV. IM, SQ | q 24 hrs for 4 days then | ||
20 mg/m2 | Intrathecal | q 24 hrs for 1 - 5 days | ||
Dacarbazine | Lymphoreticular neoplasms | 200 - 250 mg/m2 | IV | q 24 hrs for 5 days, every 21 days |
Soft tissue sarcomas | 1000 mg/m2 | IV infusion | over 6 - 8hrs, every 21 days | |
Dactinomycin | Chemotherapy | 0.015 mg/kg | IV | q 24 hrs for 3 - 5 days, wait 3 weeks then |
0.1 - 1.5 mg/m2 | IV | weekly | ||
Dalteparin | DIC, Thrombosis | 70 IU/kg | SQ | q 24 hrs |
Dapsone | Mycobacterium spp | 1.1 mg/kg | PO | q 12 hrs for 4 - 6 weeks |
Deferoxamine mesylate | Iron chelator | 10 mg/kg | IV, IM, SQ | q 2 hrs for 2 doses then q 8 hrs for 24 hrs |
Reperfusion (ischaemia) injuries | 50 mg/kg | IV | over 5 mins | |
Deprenyl | hyperadrenocorticism | 1 - 2 mg/kg | PO | q 24 hrs |
Desmopressin acetate | diabetes insipidus | 0.3 µg/kg | IM | q 12 - 24 hrs |
Desoxycorticosterone acetate | hypoadrenocorticism | 0.2-0.4 mg/kg | conjunctivally | q 24hrs, max 5mg |
Desoxycorticosterone pivalate | hypoadrenocorticism | 25 mg | IM | stat |
Dexamethasone | central oedema, spinal cord trauma, DJD, other CNS trauma | 2 mg/kg | IV | then, |
1 mg/kg | IV, SQ | q 8 - 12 hrs, then | ||
0.1 mg/kg | IV, SQ, PO | q 8-12hrs | ||
hydrocephalus | 0.25 mg/kg | IV, IM, PO | q 6 - 8 hrs | |
shock, anaphylaxis | 4 - 6 mg/kg | IV (slowly) | ||
immune-mediated disease | 0.25 - 1.25 mg/kg | PO | q 12 - 24 hrs | |
0.1 - 0.15 mg/kg | SQ, PO | q 12 hrs for 5 - 7 days, then taper dose | ||
hypoadrenocorticism | 0.1 - 0.5 mg/kg | SQ, IV | with mineralocorticoids | |
asthma | 1 mg/kg | IV | then | |
0.25 - 1.0 mg/cat | PO | q 8 - 24hrs | ||
Dexrazoxane | iron chelation for doxorubicin-induced cardiotoxicity | 25 mg/kg (ratio of 10-20:1 dexrazoxane : doxorubicin) | IV | 15 mins before doxorubicin |
Dextran 40 | Shock | 10 - 20 ml/kg | IV | q 24 hrs |
Dextran 70 | Volume expander | 10 - 20 ml/kg | IV | q 24 hrs to effect |
Dextromethorphan | coughing | 0.5 - 2.0 mg/kg | PO, SQ, IV | q 6 - 8 hrs |
Dextrose, 50% | hypoglycemia, insulin overdose | 2 ml/kg | PO | |
0.25 - 1.0 ml/kg | IV | |||
Dextrose, 5% | hypoglycemia, insulin overdose | 40 - 50 ml/kg | IV, SQ, IP | as needed |
Diazepam | Pre-med, Behavior modification | 0.5 - 2.2 mg/kg | PO | as needed |
seizures | 0.15 - 0.70 mg/kg | PO, IV | q 8 hrs | |
status epilepticus, toxins | 0.5 - 1.0 mg/kg | IV | in increments of 5 - 20 mg | |
strychnine-induced seizures | 2 - 5 mg/kg | IV | as needed | |
0.5 mg/kg | IV | |||
Dichlorphenamide | Glaucoma | 3 - 5 mg/kg | PO | q 8- 12 hrs |
Dicloxacillin | Susceptible infections | 10 - 50 mg/kg | PO | q 6 - 8 hrs |
Diethylcarbamazine | heartworm disease | 6.6 mg/kg | PO | q 24 hrs |
Diethylstilboestrol | incontinence | 0.01-0.02 mg/kg | PO | q 24 hrs |
Difloxacin | Susceptible infections | 5 - 10 mg/kg | PO | q 24 hrs |
Digoxin | Congestive heart failure | 0.005 - 0.008 mg/kg | PO | q 12 hrs |
Dihydrotachysterol | milk fever, hypoparathyroidism | 0.03 - 0.06 mg/kg | PO | q 24 hrs for 3, then |
0.01-0.02 mg/kg | PO | q 24hrs | ||
Diltiazem | hypertension, hypertrophic cardiomyopathy, supraventricular tachycardia | 0.5 - 2.5 mg/kg | PO | q 8 hrs |
Dimenhydrinate | Antihistamine | 1.0 - 3.0 mg/kg | PO, IM, IV | as needed |
Dimercaprol | Arsenic toxicosis | 2.5 -5.0 mg/kg | IM | q 4 hrs for 2 days, then q 8hrs for 3 days, then q 12hrs for 10 days |
Dimethylsulfoxide | Spinal cord trauma, amyloidosis | 0.5 - 1 g/kg | IV (10%) | q 6 - 8 hrs over 45 min |
Diminazine aceturate | Babesia spp, Trypanosoma spp | 2.0 - 3.5 mg/kg | IM | Once |
3.5 mg/kg | IM, SQ | q 24 hrs for 2 days | ||
Dinoprost | see prostaglandin F2a | |||
Diphenhydramine | Antihistamine | 2 - 4 mg/kg | PO | q 6 - 8 hrs |
mast cell tumour, antiemetic | 2 mg/kg | IM, IV | q 12 hrs as needed | |
Diphenoxylate | ulcerative colitis | 0.05 - 0.1 mg/kg | PO | q 12 hrs |
Diphenylthiocarbazone | Thallium toxicosis | 50 - 70 mg/kg | PO | q 8 hrs |
Diphemanil methylsulphate | bronchodilator | 1.8 mg/kg | IM | q 12 hrs |
Dipyridamole | thromboembolism | 4 - 10 mg/kg | PO | q 24 hrs |
Disodium EDTA | Calcium keratopathy | 0.37% solution | topically | lavage cornea for 15 - 20 mins |
Dobutamine | Positive ionotrope | 0.5 - 2.0 µg/kg/min | IV infusion (caution) | 1 min |
Dolasetron | antiemetic | 0.6 mg/kg | PO, IV, SQ | q 24 hrs |
Dopamine | hypotension, shock, inotropic agent | 2 - 25 µg/kg | IV infusion | 1 min |
Doxapram | Respiratory stimulant in neonates | 1 - 5 mg/kg | IV (umbilical vein) | as needed |
1 - 2 drops | PO | as needed | ||
Doxorubicin | chemotherapy | 10 - 30 mg/m2 | IV | q 21 days |
Doxycycline | Susceptible infections | 5 - 10 mg/kg | PO, IV | q 12 - 24 hrs |
Edrophonium | myasthenia gravis diagnosis | 2.5 mg/dog | IV | stat |
Emodepside | anthelmintic | 1 x vial | topically | monthly |
Enalapril | hypertension, congestive heart failure, valvular endocardiosis | 0.25 - 0.5 mg/kg | PO | q 12 - 24 hrs |
Enilconazole 10% | Aspergillus spp | 5% solution (1:1 in water) | topically | q 12 hrs for 7 - 10 days |
10-20 mg/kg (10% solution: 50:50 in water | instil into nasal sinus | q 12hrs for 10 - 14 days | ||
Enrofloxacin | Susceptible infections | 5.0 - 20.0 mg/kg | PO, SQ, IM, IV (with caution - may cause blindness) | q 24 hrs for 7 - 10 days |
Ephedrine | bronchodilator, incontinence | 2.0 - 5.0 mg/kg | PO | q 8 - 12 hrs |
Epinephrine | cardiac arrest | 0.2 ml/kg | IV, intratracheal | q 5 - 15 min as needed |
Epsiprantel | Dipylidium spp, Taenia spp | 2.5 - 2.75 mg/kg | PO | stat |
Ergocalciferol | Vitamin D | 500 - 2000 IU/kg | PO | q 24 hrs |
Erythromycin | Susceptible infections | 10 - 22 mg/kg | PO, IV | q 8 hrs |
Erythropoietin | anemia | 50 - 100 IU/kg | SQ | 3 x weekly for 12 weeks then twice weekly (as need to maintain PCV at 35%) |
400 IU/kg | IV, SQ | once a week | ||
Esmolol | Selective B1 blockade | 0.05 mg/kg | slow IV | loading dose, then |
50 - 200 µg/kg | IV infusion | per min | ||
Estradiol cypionate | mesalliance | 125 - 250 µg | IM | between 40hrs and 5 days post-coitus |
Ethosuximide | seizures | 40 mg/kg | PO | load, then |
20 mg/kg | PO | |||
EDTA | anticoagulant, chelation | 1 mg/kg | IV | q 2hrs |
Etidronate disodium | hypercalcaemia | 10 mg/kg | PO | q 2 hrs |
Etomidate | general anesthesia | 0.5 - 3.0 mg/kg | IV | as needed |
With opioids | 0.5-1.0 mg/kg | IV | as needed | |
Etretinate | dermatopathy | 1 - 2 mg/kg | PO | q 24 hrs |
Famotidine | antacid | 0.5 mg/kg | IM, SQ, PO | q 12 - 24 hrs |
Febantel | anthelmintic | 10 mg/kg per 1mg/kg praziquantel | PO | q 24 hrs for 3 days |
Fenbendazole | anthelmintic | 25 - 50 mg/kg | PO | q 12 hrs for 3-14 days |
Fentanyl | analgesia | 0.01 mg/kg | IV, SQ, IM | |
Fitergol | cognitive dysfunction syndrome | 1 - 5 mg/dog | PO | q 24hrs |
Flavoxate | Incontinence (Detrusor hyperspasticity) | 100 - 200 mg/dog | PO | q 6 - 8 hrs |
Florfenicol | Susceptible infections | 22 - 50 mg/kg | PO, IM, SC | q 12 hrs |
Fluconazole | fungal infections | 2.5 - 10.0 mg/kg | PO with food | q 12 - 24 hrs |
Flucytosine | Cryptococcus spp | 30 - 50 mg/kg | PO | q 6 - 8 hrs |
Fludrocortisone | hypoadrenocorticism | 0.1 - 0.2 mg/dog | PO | q 24 hrs |
Flumazenil | hepatic encephalopathy | 0.2 mg/dog | IV | as needed |
Flumethasone | anti-inflammatory | 0.15 - 0.3 mg/kg | IV, IM, SQ | q 24 hrs |
Flunixin meglamine | analgesic, anti-pyretic | 0.5 - 2.2 mg/kg | IV, IM, SQ | oid for 3 days, then repeat after 4 days |
Fluoxetine | Behavioural problems | 0.1 - 2.0 mg/kg | PO | q 24 hrs |
Flurazepam | seizures | 0.2 - 0.4 mg/kg | PO | q 4 - 7 days |
Flurbiprofen | Conjunctivitis | 0.2 - 0.4 mg/kg | Topically | q 8 - 12 hrs |
Folic acid | Dietary supplement | 0.5 - 1.0 mg/kg | PO | q 24 hrs |
Follicle stimulating hormone (FSH) | Induction of oestrus | 500 IU HCG | IV, IM, SQ | q 24 hrs for 5 days |
Fomepizole | Ethylene glycol toxicity | 20 mg/kg | IV | stat |
Furosemide | diuretic | 2 - 4 mg/kg | IV, IM, PO | q 8 - 12 hrs as needed |
Gabapentin | Epilepsy | 10 mg/kg | PO | q 8 - 12 hrs |
Gamma globulin | Immune-mediated disease | 1 g/cat | IV | q 6 - 12 hrs |
Gentamicin | Susceptible infections | 6 - 8 mg/kg | IM, SQ, IV | q 24 hrs |
Glimipiride | Non-insulin-dependant diabetes mellitus | 0.25 - 0.5 mg/kg | PO | q 24 hrs |
Glipizide | Non-insulin-dependant diabetes mellitus | 0.25 - 0.5 mg/kg | PO | q 8 - 12 hrs |
Glycopyrrolate | Bundle branch block | 0.005 - 0.010 mg/kg | IV, IM | as needed |
Gold sodium thiomalate | Immune-mediated disease | 0.25 - 1.0 mg/kg | IM | weekly x 3; 2nd + 3rd week at 2 - 10 mg/cat |
Gonadotropin releasing hormone (GnRH) | Ovarian cystadenoma, detection of ovarian remnant syndrome | 25 µg/dog | IM | single treatment |
Granisetron | Chemotherapy-associated vomiting | 0.1 - 0.5 mg/kg | IV, PO | q 12 - 24 hrs |
Granulocyte colony stimulating factor | Neutropenia | 3 - 10 µg/kg | SQ | q 12 - 24 hrs |
Griseofulvin | Antifungal | 10 - 30 mg/kg | PO | q 24 hrs for 4 weeks |
Guaifenesin | Tranquiliser | 44 - 88 mg/kg | IV | stat |
Halofuginone | Coccidiostat, Immunosuppressant | 100 µg/kg | PO | q 24 hrs |
Halothane | General anesthesia | Induction: 3% | Inhalant | stat |
Maintenance: 0.5-1.5% | Inhalant | as needed | ||
Haemoglobin (polymerised bovine) | Blood replacement | 10-30 ml/kg | IV | stat |
Heparin | Thromboembolism, thrombophlebitis | Initial dose: 100-200 IU/kg | IV | then |
Maintenance dose: 50-100 IU/kg | SQ | q 6 - 8hrs | ||
Thromboembolism | Induction 1000 IU/kg | IV | then | |
Maintenance: 50 IU/kg | SQ | q 8hrs | ||
Pancreatitis | 50-1000 IU/kg | SQ | q 8 - 12hrs | |
DIC | 75-100 IU/kg | IV, SQ | q 6hrs | |
Lipoprotein lipase provocation test | 100 IU/kg | IV | test lipids before and 15 mins after heparin | |
Heparin, LMW | see Dalteparin | |||
Hetacillin | Susceptible infections | 10 - 20 mg/kg | PO | q 8 - 12 hrs not associated with feeding |
Hetastarch (Hydroxyethyl starch) | Plasma volume expander | 10 - 20 ml/kg | IV | as needed |
Human gammaglobulin | Immune-mediated disease | 0.5 - 1.5 g/kg | IV | q 12 hrs (infusion) |
Hydrocodone | Antitussive | 0.22 mg/kg | PO | q 12 hrs |
Hyaluronate sodium | Synovitis | 0.5 - 1.0 mg/kg | intra-articular | q 7 days |
Hydralazine | Vasodilator: congestive heart failure | 0.5 mg/kg, titrate up to 0.5 - 0.8 mg/kg | PO | q 12 hrs |
Hydrochlorothiazide | Hypertension | 0.5 - 2.0 mg/kg | PO | q 12 - 24 hrs |
Nephrogenic diabetes insipidus | 0.5 - 5.0 mg/kg | PO | q 12 hrs | |
Hypoglycaemia | 2 - 4 mg/kg | PO | q 12 hrs | |
Calcium oxalate uroliths | 2 mg/kg | PO | q 12 hrs | |
Hydrocortisone | Replacement therapy | 0.5 - 1.0 mg/kg | PO | q 24 hrs |
Anti-inflammatory | 2.5 - 5.0 mg/kg | PO | q 12 hrs | |
Hydrocortisone aurate | Hypoadrenocorticism | 0.1 - 0.2 mg/kg | IM | q 8 - 12 hrs |
Immune-mediated haemolytic anaemia | 2 - 4 mg/kg | IM | q 12 - 24 hrs | |
Hydrocortisone sodium succinate | Shock | 8 - 150 mg/kg | IV | stat |
Hydrogen peroxide (3%) | Emetic | 5-10 ml/cat | PO | stat |
Hydromorphone | Analgesia | 0.05 - 0.1 mg/kg | IM, SQ | every 24 hrs |
Hydroxyurea | Primary polycythemia | 25 - 30 mg/kg | PO | q 3 days |
Chronic granulocytic leukaemia | 0.5 g/m2 | PO | q 12hrs for 4-6 weeks, then halve dosage | |
Hydroxyzine | Antihistamine | 5-10 mg/cat | PO | q 12hrs |
Hypertonic saline | Shock | 2-6 ml/kg | rapid IV infusion | stat |
Idarubicin HCl | Antiviral | 2.0 mg/kg | PO | q 24hrs for 2 days, then repeat q21 days |
Idoxuridine | Ocular herpes viral infection | 0.1% solution: 1 drop | topically | q 4 - 6 hrs |
0.5% ointment | topically | q 1 hr | ||
Imatinib mesylate | Chemotherapy | 10 mg/kg | orally | once daily |
Imidacloprid | Fleas | 100 mg/ml | topically | 0.1 cc/kg monthly |
Imidocarb | Ehrlichia spp | 5 mg/kg | IM | every 14 days x 2 |
Imidapril | Congestive heart failure and Chronic renal disease | 0.5 mg/kg | PO | q 24hrs |
Imipenem-cilastin | Susceptible infections | 2 - 10 mg/kg | IM or slow IV | q 6 - 8 hrs |
Imipramine | Behavioural modification, urinary incontinence | 2.5 - 5.0 mg/cat | PO | q 12 hrs |
Insulin, glargine | Diabetes mellitus | 0.25-5.0 U/kg | SQ | q 12hrs, adjust as needed |
Insulin, lente | Diabetes mellitus | 0.5 U/kg | SQ | q 12 - 24hrs |
Insulin, NHP | Diabetes mellitus | 1 - 3 U/dog | SQ | q 12 - 24hrs |
Insulin, PZI | Diabetes mellitus | 1 - 3 U/dog | SQ | q 12 - 24 hrs |
Insulin, regular | Diabetes mellitus | 1 - 2 U/dog | SQ | q 6 - 8 hrs |
Insulin, ultralente | Diabetes mellitus | 1-3 U/dog | SQ | q 12 - 24hrs |
Interferon a2, human recombinant | Immunostimulant | 15 - 30 U/dog | IM, SQ, PO | q 24 hrs on alternate weeks |
Iodine | Hyperthyroidism | 50 - 100 mg/dog | PO | q 24 hrs |
Iodide sodium, potassium 20% solution | Hyperthyroidism | 20 mg/kg | PO | q 12 - 24 hrs |
Iopamidol | Myelography | 0.25 ml/kg | intrathecal | stat |
Ipecac syrup | Emetic | 2 - 6 ml/dog | PO | stat |
Ipodate | Hyperthyroidism (short term) | 15 mg/kg | PO | q 12hrs |
Iron dextran | anemia | 50 mg | IM | at 18 days of age |
Isoflurane | Gaseous anaesthesia |
Induction: 5% Maintenance: 1.5-2.5% |
Inhalation | stat |
Isoniazid | Mycobacterium spp | 10 - 20 mg/kg | PO | q 24 hrs |
Isopropamide | Bundle branch block | 0.2 - 0.4 mg/kg | PO | q 8 - 12 hrs |
Antidiarrhoeal, GIT hypermotility | 0.2 - 1.0 mg/kg | PO | q 12 hrs | |
Isoproterenol | Bundle branch block | 0.04 - 0.08 µg/kg | IV infusion | as needed |
Isosorbide dinitrate | Vasodilator, osmotic diuretic, megaoesophagus | 2.5 - 5.0mg | PO | q 12 hrs |
Itraconazole | fungal infections | 5 - 10 mg/kg | PO | q 12 - 24 hrs |
Ivermectin | Heartworm disease prophylaxis | 24 µg/kg | PO | once monthly |
Kanamycin | Susceptible infections | 10 - 15 mg/kg | IV, IM, SQ | q 12 hrs |
GI tract bacterial overgrowth | 10 - 12 mg/kg | PO | q 8 - 12 hrs | |
Kaolin / pectin | GI tract protectant | 1 - 2 ml/kg | PO | q 2 - 6 hrs |
Ketamine | general anesthesia | 7 - 11 mg/kg | IV, IM | stat |
Ketoconazole | fungal infections | 5.0 - 10.0 mg/kg | PO | q 12 - 24 hrs |
Ketoprofen | analgesic | 0.2 - 1.0 mg/kg | PO, IM, SQ | q 24 hrs for less than 5 days |
L-asparaginase | chemotherapy | 10,000 U/m2 | IV | weekly as part of a protocol |
Lactated Ringer's solution | Rehydration | 40 - 50 ml/kg | IV | q 24 hrs |
Lactilol | Stool softener, hepatic encephalopathy | 250 ml | PO | q 12 hrs |
Lactoferrin | periodontitis | 40 mg/kg | Topical | q 24 hrs |
Lactulose | megacolon, hepatic encephalopathy | 2.5-5.0 ml | PO | q 8 - 12 hrs |
Lamasil | fungal infections | 20 - 30 mg/kg | PO | q 24 hrs for 4 - 10 weeks |
Leucovorin | Methotrexate toxicity | 3 mg/m2 | IM | within 3 hrs of poisoning |
Levallorphan | Opioid toxicity/overdose | 0.02 - 0.20 mg/kg | IV | as needed |
Levamisole | heartworm disease | 10 mg/kg | PO | q 24 hrs for 7 days |
Levetiracetam | seizures, cognitive disorder | 15 - 20 mg/kg | PO | q 8 - 12 hrs |
Levodopa | hepatic encephalopathy | 6.8 mg/kg initially, then 1.4mg/kg | PO | q 6 hrs |
Thyroxine | Hypothyroidism | 10-30 µg/kg | PO | q 12hrs |
Lidocaine | Ventricular arrhythmias, epidural | 0.25 - 1.0 mg/kg | IV, intrathecal | stat |
Lime sulphur | Sarcoptes spp | 1:40 dilution | Topically | weekly for 6 weeks |
Lime water | Alkaline gastric lavage | 5 ml/kg | PO | stat |
Lincomycin | Susceptible infections | 11 - 33 mg/kg | PO, IV, IM | q 12 - 24 hrs |
Lisinopril | congestive heart failure, hypertension | 0.25 - 5.0 mg/kg | PO | q 24 hrs |
Lobaplatin | chemotherapy | 35 mg/m2 | IV | q 3 hrs |
Lomustine | chemotherapy | 100-150 mg/m2 | PO | q 6 weeks (subsequent dose based on WBC) |
Loperimide | Antidiarrhoeal | 0.1 - 0.3 mg/kg | PO | q 12 - 24 hrs |
Luteinizing hormone | Stimulate ovulation | 50 IU | IM | after mating |
Magnesium sulphate (25%) | Hypomagnesemia | 5 - 15 mmol | IM, IV | over 1 - 2 hrs |
Mannitol 5-20% | oliguric renal failure | 0.25 - 1.0 g/kg | IV over 15 - 60 min | q 4 - 6 hrs to maintain urine flow |
Glaucoma | 1 - 3 mg/kg | IV over 15 - 20 min | ||
CNS oedema | 1.5 mg/kg | IV | stat | |
Marbofloxacin | Susceptible infections | 2.75 - 5.5 mg/kg | PO | q 24 hrs |
Maropitant | Anti-emetic | 1.0 mg/kg | SQ/PO | q 24 hrs for 4 days, then rest 2 days |
Mebendazole | Parasites | 22 mg/kg | PO | q 24 hrs for 3 days |
Meclizine | antiemetic | 12.5 mg | PO | q 24 hrs, 1 hr before driving |
Medetomidine | analgesia, sedative | 50-150 µg/kg | IV, IM | stat |
Medroxyprogesterone acetate | aggression | 1 - 2 mg/kg | IM | once weekly, stop 7-10 days before parturition |
Megestrol acetate | estrus suppression | 0.5 - 1.0 mg/kg | PO | q 24 hrs for 10 days, then q 48hrs for 5 treatments, then as needed |
Meglumine antimonate | Leishmaniasis | 5 - 30 ml/dog | IV, IM, IP | q 48 - 72 hrs |
Melatonin | Anterior uveitis | 0.01 - 1.0 mg | PO | q 24hrs |
Meloxicam | analgesia | 0.01 - 0.03 mg/kg | PO | q 24 hrs as needed |
Melphalan | chemotherapy | 0.05 mg/kg | PO | q 24 hrs for 2 weeks, then q 48hrs |
Mepivacaine | Local analgesia | 1 - 5 ml of 2% solution | SQ | as needed |
Mesna | Haemorrhagic cystitis associated with cyclophosphamide | 40% of cyclophosphamide dose | PO, IV, IM, SQ | q 3 hrs x 6 at time of cyclophosphamide treatment, follow with repeat dose (24 hr infusion) |
Metamucil | Laxative | 2-4 g | in moistened food | q 12 - 24 hrs |
Metaproterenol | Bronchodilation | 0.325 - 0.65 mg/kg | PO | q 4 - 6 hrs |
Metaraminol | Vascular support during shock | 0.01 - 0.1 mg/kg | IV slowly | stat |
Metformin | diabetes mellitus) | 2 mg/kg | PO | q 12 hrs |
Methazolamide | glaucoma | 1 - 2 mg/kg | PO | q 12 hrs |
Methicillin | Susceptible infections | 20 mg/kg | IM, IV | q 6 hrs |
Methocarbamol | Muscle relaxation | 20 - 66 mg/kg | PO | q 8 - 12 hrs |
Methohexital | Anaesthesia induction | 2.5% solution: 11 mg/kg | IV | stat |
Methotrexate sodium | Chemotherapy | 2.5 mg/m2 | PO | q 24hrs or 2 - 3 x weekly, in a protocol on day 14 with 5 mg prednisolone PO q 12hrs |
Carcinomas, sarcomas | 10-15 mg/m2 | PO | q 1 - 3 weeks | |
Methoxamine (a1-agonist) | Vasopressor: cardiac arrest, shock | 200-250 µg/kg or 40-80 µg/kg | IM | stat |
Methoxyflurane | Inhalation anaesthesia | Induction: 3%, Maintenance: 0.5-1.5% | Inhalation | stat |
Methscopolamine bromide | Anti-emetic | 0.3-1.0 mg/kg | PO | q 8hrs (use cautiously) |
Methylcellulose | Laxative | 1.0-1.5 g/cat | PO | as needed |
Methylene blue 0.1% | Indicator dye | 3 mg / 250 ml 0.9% NaCl | IV over 30-40 min | |
Antidote | 1-1.5 mg/kg | IV | stat | |
Methylprednisolone | Antiinflammatory | 0.5-1.0 mg/kg | PO | q 12hrs |
Methylprednisolone acetate | Asthma | 1-2 mg/kg | IM | q 7 days |
Others | 5.5 mg/kg | SQ, IM | 1 - 24 weeks | |
Methyltestosterone | Anabolic steroid | 1 - 2 mg/kg | PO | q 24 hrs |
Testosterone-responsive dermatoses | 1-2.5 mg/cat | PO | q 48hrs | |
Metoclopramide | Gastric motility disorders, antiemetic | 0.2 -0.5 mg/kg | PO, IM, SQ | q 8 hrs |
1.0 - 2.0 mg/kg | IV | q 24 hrs | ||
Gastric reflux | 0.2-0.4 mg/kg | PO | q 8hrs, 30 mins before meals | |
Metoprolol | Atrial fibrillation, hypertrophic cardiomyopathy | 0.05 - 3.0 mg/kg | PO | q 8 hrs |
Metronidazole | Colitis, Coccidiosis, anaerobic infections | 10 - 25 mg/kg | PO | q 24 hrs for 7 - 14 days |
Gingivitis | 50 mg/kg | PO | q 24 hrs | |
Metyrapone | Cushing's syndrome | 65 mg/kg | PO | q 12 hrs |
Mirtazepine | Antiemetic | 0.75 mg/kg | PO | q 3 days |
Misoprostol | Mucosal protectant | 3 - 5 µg/kg | PO | q 12 hrs as required |
Miconazole cream | Fungal infections | 1 - 3 cm | topically | q 24 hrs for 2 - 4 weeks |
Midazolam | Preanaesthetic, sedation, | 0.06 - 0.22 mg/kg | IM, IV | stat |
Control of seizures | 0.2-0.5 mg/kg | IV | stat | |
Milbemax | Heartworm and intestinal worm prophylaxis | 0.5 - 2.0 mg/kg | PO | monthly |
Silymarin | Free radical scavenger | 50 - 250 mg/kg | PO | q 12 hrs |
Mineral oil | Laxative | 5-10 ml/cat | PO, per rectum | q 12hrs |
Mithramycin | Hypercalcaemia, testicular cancer, malignancies | 0.25 - 0.50 µg/kg | IV | q 24 hrs x 2 |
Mitotane (o,p-DDD) | Pituitary-dependant hyperadrenocorticism | 25 mg/kg | PO | q 7 days (maintenance) |
Mitoxantrone | Anticancer chemotherapy | 6.0 - 6.5 mg/m2 | IV | q 3 - 4 weeks x 4 - 6 |
Morphine | Antitussive, analgesia | 0.05 - 0.1 mg/kg | SQ, IM | q 4 - 6 hrs |
Moxifloxacin | Mycobacterium spp, Bartonella spp]] | 5.0 mg/kg | PO | q 24 hours |
Naloxone | stereotypic behaviour | 20 mg | SQ | |
Shock | 2 mg/kg | IV | q 1 hr | |
Opioid antagonist | 0.01 - 0.04 mg/kg | IV | to effect, repeat as needed | |
Nandrolone | Anaemia | 2.0 - 10 mg/kg | IM | weekly |
N-acetylcysteine | see Acetylcysteine | |||
Neomycin | Susceptible infections | 7 mg/kg | IM, IV, SC | q 24 hrs (nephrotoxic) |
Hepatic encephalopathy | 10 - 20 mg/kg | per rectum | q 6 hrs | |
Neostigmine | Diagnostic aid for myasthenia gravis | 20 µg/kg with 0.04 mg/kg of atropine | IV | stat |
2 mg/kg/day | PO | q 24hrs, divided doses | ||
Niacin | Hypertriglyceridemia | 50 - 100 mg/day | PO | q 24 hrs |
Nitenpyram | Fleas | 1 tab | PO | daily as needed |
Nitroglycerin 2% ointment | Vasodilator for pre-load reduction | 1/8 - 1/4 inch (0.3-0.6cm) | cutaneously | q 6 - 8 hrs |
Nitroprusside | Acute Congestive heart failure | 0.5-10 µg/kg | IV | q 1 min |
Norepinephrine | Positive ionotrope | 0.05 - 0.3 µg/kg | IV | q 1 min |
Novobiocin | Susceptible infections | 10 mg/kg | PO | q 8 hrs |
Nystatin | Susceptible infections | 100,000 IU | PO | q 8 hrs |
Octreotide | Chylothorax, Acromegaly | 0.1 mg | SQ | q 8 hrs |
Ofloxacin | Susceptible infections | 2.5-10.0 mg/kg | PO | q 12hrs |
Omeprazole | Gastritis, gastric ulceration | 1 mg/kg | PO | q 24 hrs |
Ondansetron | Antiemetic | 0.5 - 1.0 mg/kg | PO | q 24 hrs |
Orbifloxacin | Susceptible infections | 2.5 - 7.5 mg/kg | PO | q 24 hrs |
Ovarid | (see Megestrol acetate) | |||
Oxymorphone | Preanaesthetic | 0.1 - 0.2 mg/kg | IM, IV | with ACP or atropine |
Oxytocin | Dystocia | 0.5 - 1.0 IU/kg | IV, IM, SQ | q 2 hrs for max of 3 doses |
Paclitaxel | Chemotherapy | 5 mg/kg | IV | pre-treat for anaphylaxis |
Pancuronium bromide | Paralytic agent for controlled anaesthesia | 0.044 - 0.11 mg/kg | IV | stat |
Parvaquone | Toxoplasmosis | 10 - 30 mg/kg | IM | q 24 hrs |
D-penicillamine | chronic hepatitis | 10 - 15 mg/kg | PO | q 12 hrs |
Penicillin G | Susceptible infections | 20-30 mg/kg | PO | q 6 - 8hrs |
Pentazocine | Analgesia | 2.2 - 3.3 mg/kg | IV, IM, SQ | q 4 hrs |
Pentobarbital | general anesthesia | 25 - 30 mg/kg | IV | to effect |
Status epilepticus | 5 - 15 mg/kg | IV | to effect | |
Sedation | 2 - 4 mg/kg | PO | q 6 hrs | |
Pentosan polysulfate | Disease modifying agent, arthritis | 3 mg/kg | IM, SQ | q 7 days |
Pentoxifylline | Dermatomyositis | 20 mg/kg | PO | q 8 - 12 hrs |
Autoimmune skin diseases | 10 - 15 mg/kg | PO | q 24hrs | |
Phenamidine isethionate | Babesia spp | 7.5 mg/kg | IM, SQ | q 24hrs x 2 |
Phenobarbital | Status epilepticus | 2.5 - 5 mg/kg | PO, IM, IV | q 12 hrs |
Phenoxybenzamine | Hypertension, pheochromocytoma | 0.5 mg/kg | PO | q 12 hrs |
Detrusor areflexia | 0.5 - 2.0 mg/cat | PO | q 8 - 12 hrs | |
Relaxation of urinary sphincter | 0.5 mg/kg | IV | stat | |
Endotoxemia | 2.5-10.0 mg/cat | PO | q 24hrs | |
Phentolamine | hypertension from pheochromocytoma | 0.02 - 0.1 mg/kg | IV | stat |
Phenylephrine | Vasopressor, decongestant, mydriatic | 0.15 mg/kg | IV | as needed |
Phenylpropanolamine | incontinence | 1.5 - 2.0 mg/kg | PO | q 8 hrs |
Phenytoin | Seizures, ventricular arrhythmias | 2 - 3 mg/kg | PO | q 24 hrs |
Phosphate (K or Na) | Hypophosphatemia | 4.5 mg/dl serum phosphate | IV | over 6 hrs |
Physostigmine (Syrup) | Myasthenia gravis, Glaucoma, magic-mushroom intoxication | 0.25-5.0 mg/cat | IM | q 12hrs |
Phytomenadione | See Vitamin K1 | |||
Pilocarpine 1% ophthalmic | glaucoma | 1 drop | topically | q 6 hrs |
Pimaricin | Ocular fungal infections | 1 drop | topically | q 3 - 8 hrs |
Piroxicam | Analgesia, neoplasia | 0.3 mg/kg | PO | q 24 - 72 hrs |
Plicamycin | Hypercalcemia, testicular cancer, malignancies | 0.25 - 0.50 µg/kg | IV | q 24 hrs x 2 |
Polyethylene glycol | Lubricant, intestinal cathartic | 25 ml/kg | PO | then repeat in 2-4 hrs before GI exam |
Polyethylene glycol electrolyte solution | Electrolyte replacement | 25 ml/kg | PO | q 2 - 4 hrs |
Polymixin B | Sepsis | 1 - 2 mg/kg | IV | stat |
Posaconazole | Aspergillosis | 2.5 - 3.75 mg/kg | PO | q 12 hrs |
Potassium chloride | Potassium supplementation | 0.10-0.25 ml/kg | PO | q 8hrs |
Hypokalemia | 0.5 mEq/kg | IV | not to exceed 0.5 mEq/kg/hr | |
1 - 3 mEq | PO. IV | q 24 hrs | ||
10-40 mEq/500 ml of fluid, depending on serum potassium | IV, SQ | stat | ||
Potassium citrate | Urolithiasis | 50-75 mg/kg | PO | q 12hrs |
Potassium gluconate | Hypokalemia | 5-8 mEq/dog | PO | q 12 - 24 hrs |
Potassium iodide | fungal infections | 6 - 20 mg/kg | PO | q 24 hrs for 10-14 days |
Potassium permanganate (1:2000) | Strychnine toxicosis | 5 ml/kg in gastric lavage | PO | stat |
Potassium phosphate | see Phosphate | |||
Povidone-iodine | Burns | Apply light coating | Topically | q 12 - 24 hrs |
Pradofloxacin | Broad-spectrum antimicrobial | 5 - 10 mg/kg | PO, SQ | q 24 hrs for 7 days |
Pralidoxime chloride | Organophosphate toxicosis | 20 mg/kg | IV, IM, SQ | q 12 hrs |
Praziquantel | Dipylidium spp | 5 mg/kg | PO | stat |
Paragonimus spp | 25 - 30 mg/kg | PO | q 24 hrs for 5-10 days | |
Prazosin | After load reductions | 0.5 - 2.0 mg/dog | PO | q 8 - 12hrs |
Cystitis | 0.07 mg/kg | PO | q 8 - 12 hrs | |
Prednisolone | anti-inflammatory | 1 - 2 mg/kg | PO | q 24 hrs (each evening) |
Hypoadrenocorticism | 1 mg/kg | PO | q 12 hrs | |
Prednisolone acetate | Hypoadrenocorticism | 0.1-0.2 mg/kg | IM | q 12hrs |
Prednisolone sodium phosphate | Shock | 15 mg/kg | IV | q 4 - 6hrs |
Prednisolone sodium succinate | Allergic bronchitis, asthma | 15-30 mg/kg | IV, IM | to effective dose |
Shock | 15-30 mg/kg | IV | q 4 - 6hrs | |
CNS trauma | 15-30 mg/kg | IV | then taper to effective dose | |
Pregabalin | Epilepsy | 5 -10 mg/kg | PO | q 12 hrs |
Prilium | Congestive heart failure and Chronic renal disease | 150 mg syrup | PO | 0.5ml q 24hrs |
Procainamide | Ventricular arrhythmias | 62.5 mg/dog | PO | q 6hrs |
Prochlorperazine | Antiemetic | 0.1 mg/kg | IM | q 6 hrs |
Promazine hydrochloride | Pre-anaesthetic | 2.2 - 6.6 mg/kg | IV | stat |
Antiemetic | 1-2 mg/kg | IM, IV | q 4 - 6hrs | |
Promethazine HCl | Antihistamine, antiemetic | 0.2 - 0.4 mg/kg | IV, IM, PO | q 6 - 8 hrs |
Propantheline bromide | Acute colitis, ulcerative colitis, antiemetic | 0.22 - 0.25 mg/kg | PO | q 8 hrs up to 3 days |
Detrusor hyperspasticity, urge incontinence | 0.2 mg/kg | PO | q 6 - 8hrs | |
Propriomazine | Sedation | 1.1-4.4 mg/kg | IV, IM | q 12 - 24hrs |
Propofol | General anaesthesia, status epilepticus | Induction: 6 - 8 mg/kg | IV | stat |
Induction: 2.5-4.0 mg/kg | IV | with premedication | ||
Maintenance: 0.51 mg/kg | IV | q min | ||
Propranolol | Ventricular hypertrophy, aortic stenosis, HCM | 0.4 - 1.2 mg/kg | PO | q 8 - 12 hrs |
Ventricular arrhythmias | 0.02 - 0.06 mg/kg | IV | over 2-3 min; q 8hrs | |
0.25-0.5 mg | IV | followed by | ||
2.5 - 5.0 mg | PO | q 8hrs | ||
hypertrophic cardiomyopathy, valvular insufficiency | 2.5 mg/cat | PO | q 8 - 12hrs | |
Hypertension | 2.5 - 5.0 mg/cat | PO | q 8 - 12 hrs | |
Tachyarrhythmias from endocrinopathies | 2.5-5.0 mg | PO | q 8 - 12hrs | |
Propylthiouracil (PTU) | Hyperthyroidism | 10 mg/kg | PO | q 8 hrs |
10 mg/kg | PO | q 8 - 12 hrs | ||
Prostaglandin F2 alpha | Pyometra, Cystic endometrial hyperplasia | 0.10 - 0.25 mg/kg | SQ | q 24 hrs for 3 - 5 days |
Abortion | 0.5-1.0 mg/kg; 40 days post-conception | SQ | 2 injections 24 hrs apart | |
Protamine sulphate | Heparin antagonist | 1.0-1.5 mg for every 100 IU heparin | IV | stat |
Pseudoephedrine | Nasal decongestant | 15 - 30 mg/dog | PO | q 8 - 12hrs |
Urinary incontinence | 0.2-0.4 mg/kg | PO | q 8 - 12hrs | |
Psyllium | Bulk laxative | 1 - 3 tsp | PO | q 8 - 12 hrs |
Pyrantel pamoate | Roundworm, hookworm | 10 mg/kg | PO | repeat in 2 weeks |
Pyridostigmine bromide | Myasthenia gravis(acquired) | 1-5 mg | PO | stat |
0.25 mg/kg | PO | q 24hrs | ||
Antidote (curariform) | 0.15-0.30 mg/kg | IM, IV | ||
Toxoplasma | 0.5-2.0 mg/kg | PO | q 12hrs for 14 - 28days | |
Enteroepithelial cycle | 2 mg/kg | PO | q 24hrs for 14 - 28 days | |
Quinacrine | Giardia spp, Coccidiosis | 11 mg/kg | PO | q 24 hrs for 5 days |
Ranitidine | gastritis, GI tract ulceration | 0.5 mg/kg | IV, PO, SQ | q 12 hrs |
Retinol | Dermatological lesions | 625 - 800 IU/kg | PO | q 24 hrs |
Rifampicin | Susceptible infections | 10 - 20 mg/kg | PO | q 24hrs |
Ringer's solution | Maintenance solution | 40 - 50 ml/kg | IV, SC, IP | q 24hrs |
Ronidazole (Ronivet) | Tritrichomoniasis | 30 mg/kg | PO | q 24 hrs for 14 days |
(warning: low therapeutic margin) | 20 mg/kg | PO | q 12 hrs for 14 days | |
Roxithromycin | Susceptible infections | 15 mg/kg | PO | q 24 hrs |
Secnidazole | Giardia spp | 30 mg/kg | PO | stat |
Selegiline | Cognitive disorders | 0.5 mg/kg | PO | q 24 hrs |
hyperadrenocorticism | 1-2 mg/kg | PO | q 24 hrs | |
Selamectin | Parasiticide | 6 mg/kg | Topical | q 30days |
Selenious acid, sodium selenite | Supplementation | 0.3 mg/kg | PO | stat |
Selenium | Pancreatitis | 0.1 mg/kg | IV | stat |
Senna | Constipation | 5 ml/cat | PO | q 24hrs |
Silver nitrate solution (0.5%) | Burns | Saturate wet dressing | Topically | q 12hrs |
Sulfadiazine | Burns | Apply light coating | Topically | q 12hrs |
Sodium bicarbonate | Renal failure | 10-15 mg/kg | PO | q 8hrs |
Toxicoses | 50 mg/kg | PO | q 8 - 12hrs | |
Hyperkalemic crisis | 2-3 mEq | IV | over 30 mins | |
Urine alkalisation | 0.65-5.85 g | PO | q 24hrs | |
Sodium chloride | Hypoadrenocorticism | 1-5 g | PO | q 24hrs |
Hyponatremia, acute renal failure | 1-4 g | PO | q 8hrs | |
(0.9% soln) | 40-50 ml/kg | IV, SQ, IP | q 24hrs | |
Susceptible infections | 20 mg/kg | PO | q 24 hrs for 4 - 6 wks | |
Sodium phosphate | Hypercalcemia | Dilute 1-3 g with water (1:1) and give 10-20 ml | PO | q 8 - 24hrs until stools are soft |
Sodium thiopental | Anaesthesia | 3-15 mg/kg | IV | to effect |
Sorafenib | Chemotherapy | 2 mg/kg | PO | once daily |
Sorbitol (70% soln) | Stool softener | 3 ml/kg | PO | stat |
Sotalol | Ventricular arrhythmias | 1-2 mg/kg | PO | q 12 hrs |
Spectinomycin | Susceptible infections | 5-12 mg/kg | IM | q 12hrs |
Spiramycin | Toxoplasma spp | 12.5 - 23 mg/dog | PO | q 24hrs |
Spironolactone | Diuretic: heart failure | 2-4 mg/kg | PO | |
Hyperaldosteronism | 1 mg/kg | PO | q 12hrs | |
Hepatic insufficiency | 3.0 - 4.0 mg/kg | PO | q 24 hrs | |
Spironolactone / hydrochlorothiazide | Diuretic, antihypertensive agent | 1 - 2 mg/kg | PO | q 12 - 24 hrs |
Stanozolol | Anabolic agent, anemia | 1 - 2 mg/dog | PO | q 12 hrs |
10 - 25 mg/kg | PO | q 7days | ||
Staphage lysate | Immune stimulant | 0.1 - 0.2 ml/cat | SQ | then |
incremental doses to 1.0ml | SQ | 1 - 2 for a week, then | ||
0.5 ml | SQ | weekly for 10 - 12 weeks | ||
Staphylococcal A | Immune stimulant | 20 µg/2.75kg | IP | q 3 - 5 days |
Streptomycin, dihydro | Leptospirosis, endocarditis, Mycobacterium spp, Yersinia pestis | 10 mg/kg | IM | q 6 hrs |
Succinylcholine | Paralysis | 0.06 - 0.11 mg/kg | IV | stat |
Sucralfate | Gastrointestinal ulceration | 250-500 mg/cat | PO | q 8 - 12hrs |
Hemorrhagic pancreatitis, vomiting with renal failure | 40 mg/kg | PO | q 8 hrs | |
Sulfadiazine | Nocardiosis | 220 mg/kg | PO | for 1 treatment, then |
50-110 mg/kg | PO | q 12 hrs | ||
Toxoplasmosis | 15 - 50 mg/kg (with pyrimethamine) | PO | q 24 hrs, divided, for 14 days | |
Trimethoprim/Sulphonamides | Susceptible infections | 30 mg/kg | PO, SQ | q 24hrs |
Meningitis | 15 mg/kg | PO, IV | q 8 - 12 hrs | |
Nocardiosis | 30 - 60 mg/kg | PO, SQ | q 12 hrs | |
Sulfadimethoxine | Susceptible infections | 25 - 50 mg/kg | PO, IM, IV | q 12 - 24 hrs for max of 21 days |
Coccidiosis | 55 mg/kg (loading), then 27.5 mg/kg | PO | q 24hrs | |
Sulfaguanidine | Coccidiosis | 100-200 mg/kg | PO | q 8hrs |
Sulfamethazine, sulfamerazine | Coccidiosis | 200 mg/kg (loading), then 50 mg/kg | PO | q 12 hrs |
Sulfamethoxazole | Susceptible infections | 100 mg/kg (loading), then 50 mg/kg | PO | q 12hrs |
Sulfamethoxazole/Trimethoprim | Susceptible infections | 15 mg/kg | PO | q 12hrs |
Sulfasalazine | ulcerative colitis | 250 mg/cat | PO | q 8hrs for 3 days, then q 24hrs |
ulcerative colitis | 20-25 mg/kg | PO | q 12 -24 hrs | |
Susceptible bacterial infections | 20 mg/kg | PO | q 12hrs | |
Sulfisoxazole | cystitis | 50 mg/kg | PO | q 8 hrs |
Sulfobromophthalein sodium | Hepatic function testing | 5 mg/kg | IV | collect serum 30 min after BSP injection |
Suprofen ophthalmic | Allergic conjunctivitis | 1% | Topically | q 8 - 12 hrs |
Tacrolimus | Otitis externa | 0.1% lotion | topical | q 12hrs |
Telazol | Restraint | 6.6 mg/kg | IM | stat |
Anesthesia | 11 - 15 mg/kg | IM | stat | |
Terbinafine | Fungal infections | 20 - 30 mg/kg | PO | q 24 hrs for 4 - 10 wks |
Terbutaline sulphate | Bronchodilator | 0.01 mg/kg | SQ, IM | q 4 hrs |
1.25 - 2.5 mg/cat | PO | q 8 hrs | ||
Testosterone cypionate | Hormone replacement | 2.2 mg/kg | IM | q 2 - 3 days |
Testosterone, methyl | Anabolic effects | 1-2 mg/kg; max 30 mg/day | PO | q 24hrs |
Testosterone propionate | Feline symmetrical alopecia | 12.5 mg with oestrogen | IM | stat |
incontinence | 5 - 10 mg | IM | stat | |
0.5 - 1.0 mg/kg | IM | q 2 - 3 days | ||
Tetanus toxoid | Tetanus treatment | 0.2 ml (test dose), then give 100-500 units/kg | SQ | watch for anaphylaxis for 30 min |
Tetracycline | Acute bronchitis | 10 - 25 mg/kg | PO | q 8 - 12 hrs |
Rickettsia spp | 15 mg/kg | PO | q 8 hrs for 21 days | |
Mycobacterium spp | 22 mg/kg | PO | q 8hrs | |
Susceptible infections | 1 - 5 mg/kg | IV, IM | q 8 - 12 hrs | |
Theophylline | Bronchodilator | 4 mg/kg | PO, IM | q 8 - 12 hrs |
Theo-Dur (Sustained release) | Bronchodilator | 20 - 25 mg/kg | PO | q 24 hrs, at night |
Thiabendazole | Heartworm disease adulticide | 35 mg/kg | PO | q 12 hrs for 20 days |
Strongyloides spp | 125 mg/kg | PO | q 24 hrs for 3 days | |
Thiacetarsamide | Heartworm adulticide | 2.2 mg/kg | IV | q 12 hrs for 2 days |
Thiamine | Thiamine deficiency | 1 - 2 mg/dog | IM | q 12 hrs until regression of symptoms |
100 - 250 mg/kg | SQ | q 12 hrs | ||
Thiamylal sodium | Anaesthesia | 8.8 - 13.3 mg/kg | IV | after tranquilisation |
Thioguanine | Lymphocytic and granulocytic leukaemia | 25 mg/m2 | PO | q 24hrs for 1-5 days, then 130 days |
Thyroid | Hypothyroidism | 15 - 20 mg/kg/day | PO | q 24 hrs |
Thiopentone | General anaesthesia, status epilepticus | 3 - 15 mg/kg | IV | to effect |
Thyrotropin | Provocative testing | 1 IU/kg | IM | Collect baseline and post-TSH samples |
Acanthosis nigrans, hypothyroidism | 1 - 2 IU | SQ | q 24 hrs for 5 days | |
L-Thyroxine (levothyroxine) | Hypothyroidism | 0.5 mg/m2 | PO | q 12hrs |
20 - 30 µg/kg | PO | q 24 hrs | ||
Ticarcillin | Susceptible infections | 33 - 50 mg/kg | IM, IV | q 6 - 8kg |
55-110 mg/kg | IM, Iv | q 4 - 6hrs | ||
Ticarcillin/clavulanate | As above | |||
Tiletamine / zolazepam | Minor procedure | 9.7 - 11.9 mg/kg | IM | stat |
Castration | 10.6 - 12.5 mg/kg | IM | do not exceed 72 mg/kg with repeat doses | |
Spey | 14.3 - 15.8 mg/kg | IM | stat | |
Tolazoline | Xylazine reversal | 2 mg/kg | IV | stat |
Tolfenamic acid | Analgesia | 4 mg/kg | IM, SQ, PO | q 24 hrs up to 5 days, 3 out of 7 days for long term Rx |
Toltrazuril (Baycox) | Coccidiosis | 5 - 20 mg/kg | PO | q 24 hrs x 2 - 5 treatments |
Toluene | Anthelmintic | 267 mg/kg | PO | repeat in 2 - 4 weeks |
Tramadol | Opioid analgesia | 1 - 2 mg/kg | PO | q 8 - 12 hrs |
12.5 mg/dog | PO | q 12 hrs | ||
Triamcinolone | Gingivitis, pododermatitis, acral lick granuloma | 2 - 4 mg | PO | q 24 - 48 hrs |
Pannus, episcleritis | 4 mg | Subconjunctival | stat | |
Triamterene | Diuretic | 1 - 2 mg/kg | PO | q 12 hrs |
Trientine hydrochloride | Chelating agent | 10-15 mg/kg | PO | q 12hrs |
Triflupromazine | Behaviour modification | 0.1 - 0.3 mg/kg | IM, PO | q 8 - 12 hrs |
Triiodothyronine (T3) | Hypothyroidism | 4.4 µg/kg | PO | q 8 - 12hrs |
Trilostane | Cushing's syndrome | 30 mg/kg | PO | q 12 - 24 hrs |
Trimethoprim/sulfadiazine | Susceptible infections | 15 mg/kg | PO, SQ, IV | q 8 - 12hrs |
Tripelennamine | Antihistamine | 1 mg/kg | PO, IM | q 12 hrs |
Trypan blue | Babesia spp | 4 mg/kg | IV | stat |
Tylosin | GI bacterial overgrowth | 6.6-11 mg/kg | IM | q 12 - 24hrs |
Chronic colitis | 25 mg | PO | q 8hrs | |
Urea | Osmotic | 300 mg | IV | stat |
Urokinase | thromboembolism | 90,000 IU over 20 minutes, then 45,000 IU CRI | IV | for up to 24 hrs |
Urofollitropin | Hypogonadotropic anovulation | 2 mg/dog | IM | q 24hrs |
Ursodeoxycholic acid | chronic hepatitis | 5-15 mg/kg | PO | q 24hrs |
Valproic acid | Epilepsy | 25 - 65 mg/kg | PO | with Phenobarbital |
10-105 mg/kg | PO | alone | ||
Vanadium | Hyperglycaemia | 0.2 mg/kg | PO | q 24hrs |
Vasopressin, aqueous | Central diabetes insipidus | 10 mU/cat | IV, IM | as needed |
Vasopressin, tannate in oil | Central diabetes insipidus | 2.5-5.0 U/cat | IM | q 1- 7 days |
Vecuronium bromide | Paralytic agent for controlled anaesthesia | 40 µg/kg | IV | over 30 min |
Verapamil | Supraventricular arrhythmias | 10 - 15 mg/kg | PO | q 24 hrs, divided |
Conversion of rapid supraventricular tachycardia | 1.1-4.4 mg/kg | PO | q 8 - 12hrs | |
Vinblastine | Mast cell tumour, lymphoma | 0.1 - 0.4 mg/kg | IV | q 7 - 14 days |
Vincristine | Thrombocytopenia | 0.01 - 0.025 mg/kg | IV | q 7 - 10 days |
Lymphosarcoma | 0.5-1.0 mg/m2 | IV | once weekly | |
Neoplasia | 0.5 - 0.75 mg/m2 | IV | q 7 - 14 days | |
Viokase | Exocrine pancreatic insufficiency | 325 mg | PO | with each meal |
Vitamin A | Dietary supplement | 400 U/kg | PO | q 24hrs for 10d |
Vitamin B1 | see Thiamine | |||
Vitamin B2 | 5-10 mg/cat | PO | q 24hrs | |
Vitamin B complex | Vitamin B deficiency | 0.5-1.0 ml | IV, IM, SQ | q 24hrs |
Vitamin C | see Ascorbic acid | |||
Vitamin D | Hypocalcemia | 0.02 mg/kg | PO | Initially, then |
0.01 mg/kg | PO | q 24 - 48 hrs | ||
Vitamin D2 (ergocalciferol) | Hypocalcemia | 4000 - 6000 U/kg | PO | q 24 hrs, initially, then |
500 - 1000 U/kg | PO | q 24 - 48 hrs | ||
Vitamin D3 (calcitriol - 1-25, dihydroxy vitamin D3) | Hypocalcemia | 0.03-0.06 µg/kg | PO | q 24 hrs |
Chronic renal disease | 0.025 µg/kg | PO | q 24 hrs | |
Vitamin E | myopathy, myocarditis, retinal pigment epithelial dystrophy | 10 - 20 IU/kg | PO | q 12 hrs |
Pemphigus | 400 - 600 IU/dog | PO | q 12 hrs | |
Vitamin K1 | Deficiency, hepatopathy | 1 - 3mg/kg | SQ, PO | q 12 hrs for 4 - 6 weeks |
5mg/kg | PO | q 24hrs, divided doses | ||
Warfarin | thromboembolism | 0.06 - 0.20 mg/kg | PO | q 24 hrs. Maintain PTT at 2 - 2.5 times normal |
Xylazine | Muscle relaxation | 1.1 - 2.2mg/kg | IM, SQ | stat |
Emetic | 0.44mg/kg | IM | ||
Zafirlukast | Leukotriene receptor antagonist | 0.15 - 0.2mg/kg | PO | q 12 - 24 hrs |
Zidovudine (AZT) | Antiviral | 5 - 20 mg/kg | SQ, PO | q 8 - 12 hrs |
Zinc | Antioxidant | 2 - 3 mg/kg | PO | q 24 hrs |
Zonisamide | Epilepsy | 5 mg/kg | PO | q 12 hours |